Full history for every metric is available with a Kvantra account
Medica Group Plc (MGP.L)
Key financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 34 | 39 | 47 | 37 | 62 | 77 | 47 |
| Operating profit | £m | 8 | 10 | |||||
| Net profit | £m | 4 | 7 | 8 | 1 | 5 | 7 | 8 |
| EPS reported | £ | 0.06 | 0.07 | |||||
| Operating cashflow per share | £ | 0.07 | 0.07 | |||||
| Capex per share | £ | 0.02 | 0.02 | |||||
| FCF per share | £ | 0.05 | 0.05 | |||||
| Free cash flow | £m | 6 | 7 | |||||
| Net debt | £m | 0 | -1 | |||||
| Book value equity | £m | 61 | 61 | |||||
| Book value per share | £ | 0.49 | 0.55 | |||||
| Number of shares | m | 123.6 | 111.52 | |||||
| DPS (TTM paid) | £ | 0.03 | 0.03 |
Financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 24.14 | - | |||||
| P/B LTM | x | 2.82 | 4.39 | |||||
| P/S LTM | x | 2.24 | 5.76 | |||||
| P/FCF LTM | x | 29.54 | 38.97 | |||||
| EV/EBITDA LTM | x | 11.71 | 20.73 | |||||
| EV/Sales LTM | x | 2.24 | 5.74 | |||||
| Earnings Yield LTM | % | 4.14% | 2.77% | |||||
| FCF Yield | % | 3.39% | 2.57% | |||||
| Quality | ||||||||
| ROE | % | 11.79% | 12.41% | |||||
| ROIC | % | 9.55% | 9.55% | |||||
| Operating margin | % | 10.98% | 10.98% | |||||
| Gross margin | % | 48.30% | 48.30% | |||||
| FCF/Sales | % | 7.58% | 7.58% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +29.56% | +7.59% | |||||
| Sales Growth YoY | % | +24.33% | +19.43% | |||||
| Net Income Growth YoY | % | +31.70% | +7.40% | |||||
| FCF Growth | % | -23.74% | -13.87% | |||||
| Operating Profit Growth | % | -0.97% | +2.06% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 1.93% | 1.33% | |||||
| Dividend Growth | % | -21.29% | - | |||||
| Payout Ratio | % | 46.22% | 46.22% | |||||
| FCF/Debt | x | 0.52 | 0.62 | |||||
| Net Debt/EBITDA | x | 0.01 | 0.01 | |||||
| EBIT/Net interest | x | 13.48 | 13.48 | |||||
| Net debt/market cap | % | 0.10% | -0.29% | |||||
| Net debt/Equity | x | 0.00 | -0.01 | |||||
| Gross debt/equity | x | 0.18 | 0.18 | |||||
Company overview
Medica Group Plc, along with its affiliated entities, delivers remote radiology reporting solutions to healthcare providers such as NHS trusts, private medical facility networks, and diagnostic imaging firms across the United Kingdom, Ireland, and the United States. Its service portfolio encompasses NightHawk, a critical after-hours service providing emergency interpretations by radiologists for conditions like stroke and severe trauma. The company also specializes in diverse imaging analyses including cardiac, CT colonography, PET CT, nuclear medicine, CT Cone Beam, DEXA scans, audits, and MR prostate studies. Furthermore, it offers an AI-driven CT Brain solution to detect intracranial hemorrhage within acute teleradiology reporting workflows, alongside scheduled elective scanning services. Other offerings include standard plain film and radiographer-led plain film interpretations, comprehensive managed services, ophthalmology-focused services, and a variety of imaging laboratory provisions. Established in 2004, Medica Group Plc is headquartered in Hastings, UK.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Medica Group Plc (MGP.L)
Medica Group Plc, along with its affiliated entities, delivers remote radiology reporting solutions to healthcare providers such as NHS trusts, private medical facility networks, and diagnostic imaging firms across the United Kingdom, Ireland, and the United States. Its service portfolio encompasses NightHawk, a critical after-hours service providing emergency interpretations by radiologists for conditions like stroke and severe trauma. The company also specializes in diverse imaging analyses including cardiac, CT colonography, PET CT, nuclear medicine, CT Cone Beam, DEXA scans, audits, and MR prostate studies. Furthermore, it offers an AI-driven CT Brain solution to detect intracranial hemorrhage within acute teleradiology reporting workflows, alongside scheduled elective scanning services. Other offerings include standard plain film and radiographer-led plain film interpretations, comprehensive managed services, ophthalmology-focused services, and a variety of imaging laboratory provisions. Established in 2004, Medica Group Plc is headquartered in Hastings, UK.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free